Home/Cochlear/Brett Lawrence
BL

Brett Lawrence

Chief Financial Officer

Cochlear

Therapeutic Areas

Cochlear Pipeline

DrugIndicationPhase
Nucleus Platform IterationsSevere-to-Profound Sensorineural Hearing LossCommercial (Continuous Development)
Osia System DevelopmentConductive/Mixed Hearing Loss, Single-Sided DeafnessCommercial (Continuous Development)
Software & Connectivity EcosystemHearing Loss (Support Platform)Commercial (Continuous Development)